U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07110038) titled 'DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedoti... Read More
U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07110155) titled 'Is the Evolution of the Aldosterone-renin Ratio Pre- Versus Post-operative on Day 1 Followin... Read More
U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07109895) titled 'Custom Insole With Transcutaneous Electrical Nerve Stimulation on Clinical Outcomes of Diabe... Read More
U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07108855) titled 'Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administrati... Read More
U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07108595) titled 'Efficacy and Safety of T-DXd in Patients With HER2-positive and HER2-low Metastatic Breast C... Read More
U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07108803) titled 'European Research Group on Outcomes of Surgical Treatment of Infective Endocarditis' on July... Read More
U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07110168) titled 'Robot-assisted Adrenalectomy, Feasibility and Results' on July 31. Brief Summary: To date, ... Read More
U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07108868) titled 'A Phase I Dose Finding Study of MB-CART2219.1' on July 24. Brief Summary: A Phase I dose fi... Read More
U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07108946) titled 'the Effect of Different Background Color and Skin Tone on the Accuracy of Auricular Scanning... Read More
U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07110246) titled 'Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas' on July 31. Brief Summary... Read More